Anlit adds to Omega Bites
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Israel’s Anlit is looking for partners to commercialise the latest addition to its Omega Bites range of omega-3 supplements, Omega Bites Prenatal.
You may also be interested in...
OmegaQuant's Prenatal Test Counts DHA Level To Help Prevent Premature Labor
OmegaQuant's test helps expectant mothers monitor DHA levels, data that can help prevent premature labor. The kit – a blood collection card, lancet, alcohol pad, bandage and gauze pad sent to the company for analysis – could help curb problem that costs US health care industry around $6bn annually.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.